| Hisham Hirzallah, | |
|
613 23rd St Ste 230, Ashland, KY 41101-2868 | |
| (606) 324-4745 | |
| (606) 324-4941 |
| Full Name | Hisham Hirzallah |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Interventional Cardiology |
| Location | 613 23rd St Ste 230, Ashland, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518318476 | NPI | - | NPPES |
| Entity Name | Kings Daughters Medical Specialties Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710215736 PECOS PAC ID: 6103968029 Enrollment ID: O20100217000538 |
News Archive
Scientists at the Ragon Institute - a joint enterprise of Massachusetts General Hospital, the Massachusetts Institute of Technology and Harvard University formed in 2009 to bring together diverse disciplines to work on HIV - "using a powerful mathematical tool previously applied to the stock market have identified an Achilles heel in HIV that could be a prime target for AIDS vaccines or drugs," the Wall Street Journal reports.
Investigators in The Research Institute at Nationwide Children's Hospital have developed a mouse model in which a mother's urinary tract infection negatively affects the offspring, an occurrence anecdotally observed in humans. Using this first-of-its-kind model, they have identified proteins in the blood that may indicate whether such an infection might stunt fetal growth.
Analysis of a drug regimen approved by the F.D.A. in 2006 for the treatment of non-small cell lung cancer (bevacizumab added to the standard chemotherapy regimen carboplatin and paclitaxel) finds Medicare insured patients age 65 years and older who received this regimen did not have improved survival compared to patients who received the standard treatment of carboplatin and paclitaxel alone, according to a study in the April 18 issue of JAMA.
Stage magicians are not the only ones who can distract the eye: a new cognitive psychology experiment demonstrates how all human beings have a built-in ability to stop paying attention to objects that are right in front of them.
AMGEN today announced additional results from a pivotal Phase 3 trial evaluating talimogene laherparepvec in patients with unresected stage IIIB, IIIC or IV melanoma compared to granulocyte-macrophage colony-stimulating factor (GM-CSF).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hisham Hirzallah, Po Box 2379, Ashland, KY 41105-2379 Ph: (606) 408-6200 | Hisham Hirzallah, 613 23rd St Ste 230, Ashland, KY 41101-2868 Ph: (606) 324-4745 |
News Archive
Scientists at the Ragon Institute - a joint enterprise of Massachusetts General Hospital, the Massachusetts Institute of Technology and Harvard University formed in 2009 to bring together diverse disciplines to work on HIV - "using a powerful mathematical tool previously applied to the stock market have identified an Achilles heel in HIV that could be a prime target for AIDS vaccines or drugs," the Wall Street Journal reports.
Investigators in The Research Institute at Nationwide Children's Hospital have developed a mouse model in which a mother's urinary tract infection negatively affects the offspring, an occurrence anecdotally observed in humans. Using this first-of-its-kind model, they have identified proteins in the blood that may indicate whether such an infection might stunt fetal growth.
Analysis of a drug regimen approved by the F.D.A. in 2006 for the treatment of non-small cell lung cancer (bevacizumab added to the standard chemotherapy regimen carboplatin and paclitaxel) finds Medicare insured patients age 65 years and older who received this regimen did not have improved survival compared to patients who received the standard treatment of carboplatin and paclitaxel alone, according to a study in the April 18 issue of JAMA.
Stage magicians are not the only ones who can distract the eye: a new cognitive psychology experiment demonstrates how all human beings have a built-in ability to stop paying attention to objects that are right in front of them.
AMGEN today announced additional results from a pivotal Phase 3 trial evaluating talimogene laherparepvec in patients with unresected stage IIIB, IIIC or IV melanoma compared to granulocyte-macrophage colony-stimulating factor (GM-CSF).
› Verified 1 days ago
Padma Venkatraman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Ashland Dr, Ashland, KY 41101 Phone: 606-324-1996 Fax: 606-833-2430 | |
Amr Idris, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 613 23rd St Ste 230, Ashland, KY 41101 Phone: 606-324-4745 Fax: 606-324-4941 | |
Paula K Larsen, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1000 Ashland Dr Ste G1, Ashland, KY 41101 Phone: 606-408-4900 Fax: 606-408-6643 | |
Michael Don Canty, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 617 23rd St, Suite 11, Ashland, KY 41101 Phone: 606-324-3188 Fax: 606-329-2237 | |
Dr. Ryann Acquino Pangan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 130, Ashland, KY 41101 Phone: 606-329-9335 Fax: 606-324-6383 | |
Dr. Francisco Fernandez-gonzalez, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 613 23rd St Ste 310, Ashland, KY 41101 Phone: 606-833-2161 | |
Dr. Chad Jacob Tarabolous, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 617 23rd St, Suite 19, Ashland, KY 41101 Phone: 606-325-2221 Fax: 606-324-1326 |